These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

799 related articles for article (PubMed ID: 33586566)

  • 1. Concomitant use of dexamethasone and tetracyclines: a potential therapeutic option for the management of severe COVID-19 infection?
    Singh H; Chauhan P; Singh J; Saurabh ; Gautam CS; Kakkar AK
    Expert Rev Clin Pharmacol; 2021 Mar; 14(3):315-322. PubMed ID: 33586566
    [No Abstract]   [Full Text] [Related]  

  • 2. Repurposing tetracyclines for acute respiratory distress syndrome (ARDS) and severe COVID-19: a critical discussion of recent publications.
    Garrido-Mesa J; Adams K; Galvez J; Garrido-Mesa N
    Expert Opin Investig Drugs; 2022 May; 31(5):475-482. PubMed ID: 35294307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing of Tetracyclines for COVID-19 Neurological and Neuropsychiatric Manifestations: A Valid Option to Control SARS-CoV-2-Associated Neuroinflammation?
    Chaves Filho AJM; Gonçalves F; Mottin M; Andrade CH; Fonseca SNS; Macedo DS
    J Neuroimmune Pharmacol; 2021 Jun; 16(2):213-218. PubMed ID: 33534108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible treatment and strategies for COVID-19: review and assessment.
    Trivedi N; Verma A; Kumar D
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12593-12608. PubMed ID: 33336780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing minocycline for COVID-19 management: mechanisms, opportunities, and challenges.
    Singh H; Kakkar AK; Chauhan P
    Expert Rev Anti Infect Ther; 2020 Oct; 18(10):997-1003. PubMed ID: 32552044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetracycline and viruses: a possible treatment for COVID-19?
    Mosquera-Sulbaran JA; Hernández-Fonseca H
    Arch Virol; 2021 Jan; 166(1):1-7. PubMed ID: 33136210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing existing drugs for COVID-19: an endocrinology perspective.
    Cadegiani FA
    BMC Endocr Disord; 2020 Sep; 20(1):149. PubMed ID: 32993622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review.
    Cantini F; Goletti D; Petrone L; Najafi Fard S; Niccoli L; Foti R
    Drugs; 2020 Dec; 80(18):1929-1946. PubMed ID: 33068263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Potential for Tetracyclines in the Treatment of COVID-19.
    Sodhi M; Etminan M
    Pharmacotherapy; 2020 May; 40(5):487-488. PubMed ID: 32267566
    [No Abstract]   [Full Text] [Related]  

  • 10. Tetracycline plus macrolide: A potential therapeutic regimen for COVID-19?
    Ohe M; Furuya K; Goudarzi H
    Biosci Trends; 2021 Jan; 14(6):467-468. PubMed ID: 33390423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study.
    Mühlemann B; Thibeault C; Hillus D; Helbig ET; Lippert LJ; Tober-Lau P; Schwarz T; Müller MA; ; Witzenrath M; Suttorp N; Sander LE; Drosten C; Jones TC; Corman VM; Kurth F
    Clin Microbiol Infect; 2021 Oct; 27(10):1520.e7-1520.e10. PubMed ID: 34139335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-inflammatory effects of tetracyclines.
    Weinberg JM
    Cutis; 2005 Apr; 75(4 Suppl):6-11. PubMed ID: 15916224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining hydroxychloroquine and minocycline: potential role in moderate to severe COVID-19 infection.
    Gautam SS; Gautam CS; Garg VK; Singh H
    Expert Rev Clin Pharmacol; 2020 Nov; 13(11):1183-1190. PubMed ID: 33008280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Key benefits of dexamethasone and antibody treatment in COVID-19 hamster models revealed by single-cell transcriptomics.
    Wyler E; Adler JM; Eschke K; Teixeira Alves G; Peidli S; Pott F; Kazmierski J; Michalick L; Kershaw O; Bushe J; Andreotti S; Pennitz P; Abdelgawad A; Postmus D; Goffinet C; Kreye J; Reincke SM; Prüss H; Blüthgen N; Gruber AD; Kuebler WM; Witzenrath M; Landthaler M; Nouailles G; Trimpert J
    Mol Ther; 2022 May; 30(5):1952-1965. PubMed ID: 35339689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the local applications of antibiotics and antibiotic-based agents in endodontics and dental traumatology.
    Mohammadi Z; Abbott PV
    Int Endod J; 2009 Jul; 42(7):555-67. PubMed ID: 19467048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone may improve severe COVID-19 via ameliorating endothelial injury and inflammation: A preliminary pilot study.
    Kim WY; Kweon OJ; Cha MJ; Baek MS; Choi SH
    PLoS One; 2021; 16(7):e0254167. PubMed ID: 34214123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].
    Plaze M; Attali D; Petit AC; Blatzer M; Simon-Loriere E; Vinckier F; Cachia A; Chrétien F; Gaillard R
    Encephale; 2020 Jun; 46(3S):S35-S39. PubMed ID: 32387014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lidocaine reinforces the anti-inflammatory action of dexamethasone on myeloid and epithelial cells activated by inflammatory cytokines or SARS-CoV-2 infection.
    Elizagaray ML; Mazitelli I; Pontoriero A; Baumeister E; Docena G; Raimondi C; Correger E; Rumbo M
    Biomed J; 2023 Feb; 46(1):81-92. PubMed ID: 35948250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic.
    Noreen S; Maqbool I; Madni A
    Eur J Pharmacol; 2021 Mar; 894():173854. PubMed ID: 33428898
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 40.